Clinical Trial Update: Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on combined nivolumab and adoptive T cell therapy in metastatic melanoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Nantes University Hospital | Conditions: Melanoma | Phase 1, Phase 2 | Status: UNKNOWN